L. pneumophila is an environmental organism and, therefore, an opportunistic and accidental pathogen of humans. As a result, there has been no selective pressure on the evolution of
L. pneumophila from the mammalian immune system. In general, a robust early inflammatory response is believed to control bacterial replication while cell-mediated immunity contributes to the resolution of the infection and bacterial clearance. Different animal models of
L. pneumophila infection have been established to examine the host-pathogen relationship. Indeed, the isolation of
L. pneumophila from the 1976 outbreak was facilitated by the intraperitoneal inoculation of guinea pigs with lung tissue from infected humans (
223). Guinea pigs are highly susceptible to
L. pneumophila infection, die within 3 days of aerosol exposure to the bacteria, and exhibit many clinical features associated with Legionnaires' disease of humans (
33). In contrast, inbred strains of mice are largely resistant to
L. pneumophila infection, with the notable exception of the A mouse strain (often called A/J, although this terminology refers only to mice derived directly from the Jackson Laboratories), which, when inoculated intratracheally with
Legionella bacteria, develop acute lung inflammation (
54,
124). However, even in A mice, the infection is self-limiting. The exception to the general rule of murine resistance to
Legionella infection is
L. longbeachae, which is highly virulent for a variety of inbred mouse strains (
148). Several other
Legionella species also replicate in murine macrophages (
181,
355) and, if given a high-enough inoculum, may also replicate in whole animals. Nevertheless, while the guinea pig infection model is superior in replicating much of the clinical course of Legionnaires' disease, the mouse model has been favored by research groups around the world due to the availability of reagents and transgenic animals to study immune responses and pathogenesis.
Importance of Innate Immunity to Legionella Responses in Mice
Despite the significant shortcomings of the mouse infection model for Legionnaires' disease, the fact that mice are by and large resistant to
L. pneumophila infection has allowed investigators to identify elements of the immune response that are critical to the control of
L. pneumophila replication in macrophages and in the lung. Crosses between the permissive A strain and highly resistant C57BL/6 mice allowed the unique susceptibility of A mice to be mapped to the lgn1 locus on chromosome 13 (
34,
104). Within this region are a series of highly polymorphic repeats of neuronal apoptosis-inhibitory protein (Naip), also known as baculoviral IAP (inhibitor of apoptosis) repeat-containing 1 (Birc1) (
151,
361). Variations, either by missense polymorphisms or altered expression levels, in Naip5/Birc1e alleles have been defined as the basis for the susceptibility of the A mouse strain to
L. pneumophila (
105,
359). Naip5 is an intracellular flagellin recognition molecule that shows homology to plant resistance proteins involved in innate immune responses to secreted bacterial virulence proteins (
178). In macrophages, Naip5 activates caspase-1 upon the phagocytosis of
L. pneumophila, leading to IL-1β production and an increased fusion of the LCV to endosomes, followed by bacterial degradation (
363). Although a Naip5 equivalent is not found in humans, a study of Ipaf, another intracellular flagellin recognition molecule, produced similar findings, where Ipaf was shown to restrict
L. pneumophila replication (
12). Both Naip5 and Ipaf detect cytosolic flagellin, and either the deletion of flagellin from
L. pneumophila or the deletion of Naip5 or Ipaf from nonpermissive macrophages reverses the restriction of
L. pneumophila intracellular replication (
12,
231,
273).
Since the publication of the first
in vivo mouse model of
L. pneumophila infection (
162), various studies have identified key components of the innate immune response as being important for limiting and eliminating infection. These components include cytokines such as gamma interferon (IFN-γ) (
54,
303), tumor necrosis factor alpha (TNF-α) (
56,
133), IL-12 (
57), and IL-18 (
55) as well as the cell types that produce these cytokines, namely, neutrophils (
101) and natural killer (NK) cells (
20,
101).
More recently, investigations of the innate immune response to
L. pneumophila have focused on Toll-like receptors (TLRs), a group of receptors that recognize various microbial products that trigger an innate immune response upon binding a specific ligand. Considerable study has also been directed toward myeloid differentiation primary response gene 88 (MyD88), an important adaptor molecule for most TLR signaling. MyD88-deficient mice infected with
L. pneumophila have an increased bacterial burden in the lung and decreased survival rates, develop more severe lung pathology, and suffer disseminated bacterial infection in the spleen compared to wild-type mice (
20,
157). However, investigations of individual TLRs such as TLR2, TLR4, TLR5, or TLR9 have revealed that their contribution to
L. pneumophila resistance is negligible or, at best, very modest compared to that of MyD88 (
21,
41,
156,
157,
197,
248,
315). For example, in an attempt to determine if multiple TLRs were responsible for the MyD88-dependent immune response to
L. pneumophila, TLR2/9-deficient mice were infected with a flagellin-null (Δ
flaA) mutant strain of
L. pneumophila. By using this strategy, the combined contribution of TLR2, TLR5, and TLR9 to the immune response to
L. pneumophila could be assessed. The Δ
flaA bacterial burden in TLR2/9-deficient mice was similar to that of control mice, suggesting that the MyD88-dependent immune response was not restricted to the actions of TLR signaling (
20). MyD88 also functions as an adaptor molecule for IL-1 and IL-18 receptor signaling, both of which are induced upon
L. pneumophila infection (
12,
216,
293,
363). The fact that
L. pneumophila infection of caspase-1-deficient mice results in significantly higher bacterial loads in the lung and significantly less IL-18 production than that in control mice indicates that caspase-1- and Ipaf-deficient mice are more susceptible to
L. pneumophila infection due to reduced IL-18 (or IL-1β) signaling that is MyD88 dependent (
66).
Apart from the activation of the inflammasome through Ipaf and Naip5,
L. pneumophila has diverse effects on cytokine signaling pathways. In macrophages,
L. pneumophila stimulates cytokine activity in a TLR- and RIP2-independent and Dot/Icm-dependent manner (
302). In fact, robust mitogen-activated protein kinase (MAPK) signaling (p38 and Jun N-terminal protein kinase [JNK]) is induced in response to the Dot/Icm system in infected macrophages, and the fact that
icmS and
icmW mutants do not induce MAPK activation suggests that one or more Dot/Icm effectors are either directly or indirectly responsible (
302). The consequences of MAPK activation for
L. pneumophila replication are unknown, but this activity may constitute an important host response to infection
in vivo. Certainly, in amoebae,
L. pneumophila inhibits the equivalent of the MAPK pathway by inducing the expression of DupA, a tyrosine kinase/dual-specificity phosphatase, which is likely to be a negative regulator of MAPK signaling (
200).
L. pneumophila upregulates MAPK phosphatases in macrophages, which supports the idea that this pathway is manipulated during infection (
208).
The induction of a robust type I interferon response was also observed during infection of macrophages and epithelial cells with
L. pneumophila (
204,
256,
295,
302). Exogenous type I interferon restricts
L. pneumophila replication in permissive macrophages, while endogenous type I interferon restricts
L. pneumophila replication in nonpermissive macrophages (
234,
262,
295). As evidence for the latter, macrophages from type I interferon receptor-deficient mice support
L. pneumophila replication (
90,
234,
262,
295). The type I interferon response is independent of flagellin and results from the transfer of nucleic acid to the cell cytosol through a Dot/Icm-dependent process (
90,
234,
322). Until recently, it was thought that bacterial DNA was recognized by a cytosolic DNA sensor (
322). However, it has now been shown that RNA stimulates the type I interferon response through the host helicases RIG-I and MDA5 and the adaptor Ips-I, a pathway previously known to respond only to viral infections (
76,
234). The source of RNA may originate from the pathogen or from RNA generated by host RNA polymerase III acting on pathogen-derived DNA (
76,
234). The latter possibility seems unlikely given that cytosolic
L. pneumophila DNA alone does not stimulate an Ips-I-dependent type I interferon response in macrophages, even in the presence of RNA polymerase III (
234). Therefore,
L. pneumophila may translocate RNA into the host cytosol, or alternatively, as-yet-unknown Dot/Icm effectors may stimulate the production of RNA intermediates in the host cell that then stimulate RIG-I/MDA5 signaling (
234). Given the currently accepted view that
L. pneumophila has not evolved to avoid the mammalian immune system, it is surprising that the Dot/Icm effector SdhA is a potent inhibitor of the type I interferon response (
234). Ectopically expressed SdhA inhibits the RIG-I/MDA5 pathway, although it is not yet clear if this occurs through a direct interaction or whether the inhibition results from an indirect effect of SdhA on mitochondria. Since SdhA is also implicated in inhibiting host cell death (
196), the two effects of SdhA on macrophages could be linked. Despite the effort that has gone into characterizing the mechanism of type I interferon induction, Ips-I- and type I interferon receptor-deficient mice are no more susceptible to
L. pneumophila infection, indicating that the type I interferon response is dispensable for limiting
L. pneumophila infection
in vivo, at least in mice (
234; D. K. Y. Ang, E. L. Hartland, and I. R. van Driel, unpublished data).
Few studies have examined other
Legionella species in animal infection models; however,
L. micdadei does not infect the lungs of A mice as readily as
L. pneumophila, highlighting differences in pathogenicity between
L. pneumophila and
L. micdadei in mice (
138). A study of the ability of
L. longbeachae isolates to infect guinea pigs also demonstrated that there was a substantial variation in the virulences of different
L. longbeachae strains in this infection model (
110). Strains of
L. longbeachae serogroup 1 are highly virulent in mice, with the intratracheal inoculation of 10
3 bacteria capable of causing disease (
148). Unlike
L. pneumophila, mouse infection with
L. longbeachae is not restricted to A mice, and both BALB/c and C57BL/6 mice are also susceptible to infection with serogroup 1 strains (
148). This difference in virulence may in part be related to the fact that
L. longbeachae serogroup 1 strains are nonmotile, as the deletion of flagellin from
L. pneumophila also increases the virulence and host range of the pathogen for mice (
148,
273).
Innate Immune Responses to Legionella during Human Infection
Although the characterization of innate immune responses to
L. pneumophila infection of mice is well investigated, far less is known about the innate immune response during legionellosis in humans. Certainly, the great majority of people exposed to
L. pneumophila remain asymptomatic or suffer only a mild self-limiting infection. Risk factors associated with the development of severe disease include age, smoking status, male gender, chronic obstructive pulmonary disease, alcohol intake, and immune suppression (
324). A retrospective analysis of Legionnaires' disease patients showed that these individuals released less IFN-γ in response to bacterial LPS than non-Legionnaires' disease patients, suggesting that an impairment in the IFN-γ response may also increase susceptibility to the disease (
199). In general, patients with acute Legionnaires' disease have elevated serum levels of IFN-γ and IL-12, which are typical of a Th1-type response (
331). This finding is supported by
in vitro studies showing that primary human macrophages or cell lines derived from human macrophages or epithelial cells produce a Th1-type cytokine response following
L. pneumophila infection that ultimately restricts bacterial replication (
42,
220,
243,
348). Thus, an early and robust inflammatory response appears to be critical to limit infection.
Attempts to examine possible genetic susceptibilities to Legionnaires' disease are frustrated by the small numbers of patients in disease cohorts. Nevertheless, the examination of patient genotypes in a large outbreak of Legionnaires' disease at a flower show in the Netherlands correlated some human TLR polymorphisms with the development of disease independently of other risk factors. A common TLR5 polymorphism that introduces a premature stop codon (TLR5
392STOP) occurs in around 10% of the population and is associated with a small but significantly increased risk of Legionnaires' disease (
159). In heterozygotic individuals, the TLR5
392STOP polymorphism is dominant and impairs the production of proinflammatory cytokines. As the recognition of bacterial flagellin by TLR5 on alveolar epithelial cells is a major driver of an IL-8 and IL-6 response, the TLR5
392STOP mutation likely increases an individual's risk of Legionnaires' disease by weakening the cytokine response (
159). These results support findings from the mouse model of
L. pneumophila infection where deficiencies in the recognition of flagellin by the innate immune system also increase susceptibility to infection. In contrast, a polymorphism in the TLR4 receptor TLR4
A896G was associated with an increased resistance to Legionnaires' disease despite the fact that
L. pneumophila LPS does not strongly activate inflammatory signaling through TLR4 (
158). Another innate immune factor that has been associated with resistance to
L. pneumophila infection is mannose binding lectin (MBL). Patients with Legionnaires' disease show impaired MBL-mediated complement activation (
116,
164). However, this deficiency does not reflect an underlying genetic predisposition to Legionnaires' disease but rather appears to be a physiological consequence of severe
L. pneumophila infection (
117,
164).
Interactions with the Adaptive Immune System
Although a vigorous inflammatory response is critical for limiting bacterial infection of the lung during Legionnaires' disease, T and B cells are ultimately required for the clearance of the infection. Evidence for the role of T cells comes from the depletion of CD4 or CD8 T cells using monoclonal antibodies, which resulted in decreased survival rates for mice infected with high doses of
L. pneumophila compared to nontreated animals (
326). For mice infected with lower doses of
L. pneumophila, CD4 or CD8 T-cell-depleted animals were unable to clear the bacteria from their lungs for up to 11 days after inoculation (
326). In all cases, animals depleted of both CD4 and CD8 T cells were more severely affected than mice depleted of only one subset (
326). Another study showed that mice immunized with
L. pneumophila-pulsed, fractalkine-expressing DCs were protected from a lethal dose of
L. pneumophila. This protection was completely abolished in CD4 T-cell-, CD8 T-cell-, and B-cell-deficient animals (
190). These results demonstrate that T and B cells are essential for protecting mice against
L. pneumophila infection. However, the exact mechanisms by which these cells become activated and confer protection are still largely unexplored.
T cells become activated after recognizing their antigen via the presentation of peptide-major histocompatibility complexes (MHCs) by antigen-presenting cells (APCs). The primary APC is the dendritic cell, and several studies performed with mice have implicated this cell type as the APC responsible for initiating the adaptive immune response to
L. pneumophila. For example, murine bone marrow-derived dendritic cells (BMDCs) infected with
L. pneumophila are able to stimulate IFN-γ production by CD4 T cells
in vitro (
245). This activation of CD4 T cells was dependent on the successful formation of the LCV and the prevention of lysosome fusion by the bacteria (
245). Interestingly, this scenario also occurred with murine bone marrow-derived macrophages, although BMDCs stimulated more IFN-γ production in CD4 T cells than did macrophages (
245,
246). These data indicate that although
L. pneumophila is sequestered in the LCV, this is insufficient to prevent the presentation of bacterial antigens to CD4 T cells. The exact mechanisms by which the bacterial antigens are processed and presented by MHC class II molecules are still unknown. BMDCs that come into contact with
L. pneumophila also upregulate fractalkine (CX3CL1), a strong chemoattractant for T cells (
190). In contrast to macrophages, murine BMDCs restrict the intracellular growth of
L. pneumophila (
245). This and the fact that BMDCs undergo rapid apoptosis upon
L. pneumophila infection may be a mechanism that not only prevents bacterial dissemination but also delays antigen presentation and the activation of
L. pneumophila-specific T cells (
255).
Early studies showed that a cell-mediated immune response to
L. pneumophila also occurs in humans (
43,
169). Although there is a paucity of information on the nature of this response, patients with immune deficiencies resulting from corticosteroid therapy and some types of leukemia are at an increased risk of severe and persistent Legionnaires' disease (
165,
296).
L. pneumophila infections are uncommon in patients with AIDS (
122), although some reports suggested that the disease is more severe (
261). The nature of the effector cells controlling
L. pneumophila infection in humans is not clear, but
in vitro studies show that Th1-type CD4 T cells respond to
L. pneumophila by secreting IFN-γ (
193).
Immune regulation has emerged in recent times as an important concept describing the delicate balance between protective immune responses to pathogens and damaging immune-mediated pathology. During
L. pneumophila infection of mice, it appears that this balance may be achieved via the production of prostaglandins by infected macrophages, which in turn inhibit IFN-γ production in T cells (
246). It will be interesting to see if other aspects of immune regulation such as CD4
+ Foxp3
+ T-regulatory cells also play a role in regulating the cell-mediated immune response to
L. pneumophila.
Both patients and laboratory animals produce antibodies in response to
L. pneumophila infection. Major characterized antigens include lipopolysaccharide, the Msp/ProA protease, flagellin, Hsp60, and OmpS (
45,
48,
132,
276,
352). Early studies investigated the potentials of several of these antigens in the development of vaccines to
L. pneumophila, and although some antigens showed significant promise in animal infection models, there has been little activity in this area in recent years (
44-
48,
276). Nevertheless, vaccine studies have informed our understanding of the immune control of
L. pneumophila infection and support a role for both antibody- and cell-mediated immunity in the clearance of the bacteria from the lung (
46,
48,
276).